본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Accegen

[Accegen] KMS-11

Cat-No. ABC-TC0524

upload_image



미국 Accegen은 생명과학 연구와 의약품 개발을 지원하기 위해 다양한 세포주와 생물학적 제품을 제공하는 바이오 제품 제조 기업입니다.








제품 설명


Immortalized Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells




제품 번호


ABC-TC0524




제품 특징


Product Code

KMS11; kms11; kms 11

Species

Human

Cat.No

ABC-TC0524

Product CategoryTumor Cell Lines
Size/Quantity

1 vial

Cell Type

Lymphocyte-like

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Pleural Effusion

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Myeloma Cell Lines



Description

Human Myeloma Cell Line KMS-11 is derived from pleural effusion of a 67-year-old Japanese female patient with multiple myeloma. These cells are B-cell type and exhibit small round morphology with some multinucleate forms. They secrete immunoglobulin κ (IgG κ) and show positive reaction with PCA-1. KMS-11 has chromosomal abnormalities. The cell line carries a FGFR3 gene mutation (p.Tyr373Cys) and expresses high levels of tumor markers. In terms of tumorigenicity, KMS-11 does not show tumor formation in subcutaneous nude mouse models. They display unique growth properties, including both adherent and suspension growth, making them a valuable model for studying tumor cell heterogeneity and microenvironment adaptation. KMS-11 is widely used in studies on multiple myeloma, immunoglobulin synthesis, and drug screening.



Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

    • KMS-11 can be used to map proliferation-related signaling pathways in myeloma and identify inhibitors for myeloma cell growth and survival.For example, Interleukin-6 (IL-6) was identified as one of the most important growth factors for myeloma cells, inducing enhanced growth in KMS-11 cells, accompanied by down-regulation of protein kinase C (PKC) activity. JAK inhibitor, which can affect the IL-6/JAK signal transduction, induced cell death of the KMS-11 cells and inhibited tumor growth in a KMS-11 xenograft mouse model. For drug development, ginseng was observed as a candidate for the treatment of myeloma. IH901, a derivative of ginseng,triggered several biochemical events, including the cleavage of poly (ADP-ribose) polymerase (PARP), internucleosomal DNA fragmentation, the activation of caspase-3, the down-regulation of FGFR3, the inhibition of ERK activity, and the apoptosis in KMS-11 cell line.


  • Recommended Medium And Supplement



Accegen의 모든 제품들을 만나 보세요!

 

PRODUCTS



Accegen - Official Distributor in South Korea "Morebio" 한국 공식 대리점 "모아바이오"